Klinicka bolnica Merkur
Zagreb 10000
1 studies enrolling now · 2 studies all time
What they study most
Chronic Lymphocytic Leukemia, Multiple Myeloma
Studies at this site
- MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) — Recruiting now
- Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia — Stopped early